Miglustat 100 MG capsule UD 90S
Ended Awarded
- Contract number
- SPE2DB25FD7B8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,714
Award facts
- Contract value 100% obligated
- $55,714.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Miglustat 100 mg capsules in unit dose packaging (90-count), valued at $55,714.00. This firm fixed-price delivery order, with a completion date of July 30, 2025, represents a pediatric and adult treatment option for Gaucher disease, a rare genetic disorder. The contract was competitively awarded with no set-aside provisions, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement standards through open competition.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, leverages this contract to serve critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FD7B8?
SPE2DB25FD7B8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FD7B8 worth?
The government has obligated $55,714 on SPE2DB25FD7B8.
Is contract SPE2DB25FD7B8 an order under another contract?
Yes. SPE2DB25FD7B8 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD7B8 competed?
The extent of competition for SPE2DB25FD7B8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award